Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

S Sridhar resigns as MD of Pfizer

admin by admin
August 11, 2022
in Pharmaceutical


New Delhi: Drug firm Pfizer has announced that its Managing Director S Sridhar has resigned from the company. Sridhar has expressed his intention to take early retirement and has tendered his resignation, the company said in a regulatory filing.

He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, it added.

Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years.

Read also: Pfizer to purchase Global Blood Therapeutics for USD 5.4 Billion

Over the past six years, he has led Pfizer as Managing Director and made significant contributions to the growth of the company’s portfolio and presence across India, the drug firm stated.

Sridhar has also served as the Co-Chair of the FICCI Pharmaceuticals Committee and currently also serves as the President of the Organization of Pharmaceuticals Producers of India (OPPI).

Read also: Israel Makov to step down as Sun Pharma Chairman



Source link

Tags: Managing DirectorOPPIOrganisation of Pharmaceuticals Producers of Indiapfizerpfizer newsS Sridhar
Previous Post

Companies Selling Drugs for Mole, Tag Removal Get FDA Warning

Next Post

Medicare cuts undermine the movement to increasing in-home care

Next Post

Medicare cuts undermine the movement to increasing in-home care

Recommended

Spondyloarthritis May Go Undiagnosed in Many With Uveitis

August 9, 2022

Brexpiprazole Gets Priority Review for Agitation With Alzheimer Dementia

January 10, 2023

Don't miss it

Pharmaceutical

AbbVie to lift $2B deal cap as Humira rivals appear

February 6, 2023
Medicines & Healthy Lifestyle

Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued

February 6, 2023
Medicines & Healthy Lifestyle

Low Sex Drive Can Be Treated By Hormone Injections, Study Shows

February 6, 2023
News

USTR Seeks Public Comment on Restoring Tariffs on Chinese Medical Products

February 6, 2023
Pharmaceutical

Health Bulletin 6/ February/ 2023

February 6, 2023
Pharmaceutical

FDA: Base blood donation policy on science, not stigma

February 5, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.